$1.410
+0.063 (+4.44%)At close
SNDL Revenue Streams
SNDL Inc (SNDL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Liquor retail revenue, accounting for 53.1% of total sales, equivalent to CAD 104.08M. Other significant revenue streams include Retail and Provincial boards. Understanding this composition is critical for investors evaluating how SNDL navigates market cycles within the Pharmaceuticals industry.
SNDL Profitability and Margins
Evaluating the bottom line, SNDL Inc maintains a gross margin of 19.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1.38%, while the net margin is -21.54%. These profitability ratios, combined with a Return on Equity (ROE) of -5.55%, provide a clear picture of how effectively SNDL converts its operational activities into shareholder value.
SNDL Comparative Benchmarking
In the context of the broader market, SNDL competes directly with industry leaders such as VFF and ALCO. With a market capitalization of $347.03M, it holds a significant position in the sector. When comparing efficiency, SNDL's gross margin of 19.00% stands against VFF's 46.85% and ALCO's 44.76%. Such benchmarking helps identify whether SNDL Inc is trading at a premium or discount relative to its financial performance.
SNDL Inc Financial Performance
SNDL's revenue for Q2 2026 was C$235.7 million, reflecting a nearly 4% year-over-year decline, and the company has experienced a net loss in multiple recent quarters, indicating ongoing financial challenges.
Financials
Related articles
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.